Address: Av. Int. Tomkinson 2054 – B1642EMU – San Isidro – Pcia. de Buenos Aires,Argentina
Tel: 4732 8300
Web: http://www.hlbpharma.com/
Founded in 2004 by Hernán López Bernabó, HLB Pharma was formed on the unique idea that a local company established to work to international standards would be the partner of choice for multinational corporations looking to produce in Argentina. This turned out to be a very successful strategy, and from the company’s first partner, Aventis, HLB Pharma now works with more than twenty companies, working to CGMP in many therapeutic areas.
In 2006, HLB Pharma expanded its operations to include its own pharmaceutical division, which is going from strength to strength. Today, the company is looking to expand its international reach, and continue to offer leading service to those that are looking to produce in Argentina.
Manufacturing Agreements, Quality Control Services, Quality Assurance Services, Pharmaceutical Development, Analytic Development, Dossier Development, Stock Management, Administrative Support to Clinical Research Organizations (CROs), Gastroenterology, Central Nervous System, Dermatology, Image Diagnostic, Clinical medicine, Oftalmology
Your entry into the Argentinean pharmaceutical market in 2004 was very unconventional, with your ‘holistic solution’ that had not been seen before in Argentina. Why was the time right in…
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
KPMG’s lead healthcare consultant in Argentina gives an in-depth analysis of the long-term needs and objectives driving change in the industry, the structural issues that need to be overcome before…
The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader…
Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry in Argentina and the region at BioArgentina 2014, an event…
Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the…
Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical…
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations. How did you become part of Glenmark,…
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
See our Cookie Privacy Policy Here
